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Objective. Obesity is a signiﬁcant contributor to oxygen demand and dynamic airway obstruction. The objective of the current
study is to determine the long-term success of conservative measures directed toward weight reduction on airway management
without respect to speciﬁc airway disease etiology. Methods. Patients with chronic airway obstruction secondary anatomic lesions
or obstructive sleep apnea were recruited and followed prospectively. Demographics, initial and ﬁnal weights, diagnosis, and
followup information were recorded. Patients were referred to a registered dietician, provided counseling, and started on a weight-
loss regimen. Outcome measures were change in body mass index (BMI) and rate of decannulation from weight loss alone. Results.
Of fourteen patients, ten remained tracheostomy-dependent and four had high-grade lesions with the potential for improvement
in oxygen demand and dynamic airway collapse with weight loss. The mean follow up period was 25 months. The mean change
in BMI was an increase of 1.4kg/m2 per patient. Conclusions. Conservative measures alone were not eﬀective in achieving weight
reduction in the population studied. This may be due to comorbid disease and poor compliance. The promise of decannulation
was an insuﬃcient independent motivator for weight loss in this study. Although the theoretical beneﬁts of weight loss support its
continued recommendation, the long-term success rate of conservative measures is low. More aggressive facilitated interventions
including pharmacotherapy or bariatric surgery should be considered early in the course of treating airway disease complicated by
obesity.
Copyright © 2009 R. C. Case and J. Schweinfurth. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
The beneﬁts for weight loss in the obese patient are
numerous. In today’s society, laymen are aware of the health
beneﬁts to weight reduction that essentially aﬀect every
system of the body. Many of the beneﬁts such as lower blood
pressure, better lipid proﬁles, and glucose control have a
profound impact on long-term health, but the patients may
not feel the beneﬁt in the short-term and thus revert to their
previous lifestyle after having no apparent immediate beneﬁt
from weight loss. Studies have shown that weight loss has
beneﬁcial eﬀects on clinical status in obese patients with air-
way disorders that is obvious to the patient such as decreased
dyspnea and increased exercise tolerance [1, 2]. The question
remains as to whether the immediate beneﬁts of weight
loss in obese patients with airway disorders will provide the
motivation for that population as a whole to lose weight.
An association between obesity and chronic respiratory
disease is becoming more apparent as the incidence of
obesity is increasing. Most respiratory and airway disorders
have been shown to be aﬀected in some way by obesity
[3, 4]. For example, in asthma and chronic bronchitis,
excess weight is thought to contribute through a decrease
in pulmonary compliance as well as through the production
of inﬂammatory mediators [3, 4]. Excess weight contributes
to upper airway obstruction both through an increase in
pharyngeal mass, narrowing of the upper airways, and
increased work of breathing and oxygen demand [5].
It has been established that obesity increases oxygen
demand during exercise. Recent studies have further shown
that obesity also increases oxygen consumption (VO2)a t
rest [6]. The mechanism is thought to be the increased
circulatory burden posed by excess adipose tissue. The
obese patient with upper airway disease is, therefore, at2 International Journal of Otolaryngology
Table 1: Demographics and weight loss outcomes.
Age Sex Number of Visits Initial BMI Final BMI Δ BMI Etiology of airway obstruction
46 Male 6 42.9 39.7 −3.2 OSA
56 Female 32 43.9 43.7 −0.2 Subglottic stenosis, trachmalacia
45 Female 19 28 34.3 6.3 BTVC paralysis
36 Male 14 57.9 71.6 13.7 OSA, laryngomalacia
26 Female 9 43.7 44.2 0.5 Subglottic stenosis
44∗ Male 16 40 39.9 −0.1 BTVC paralysis
32∗ Female 7 48.3 40.3 −8 OSA, tracheomalacia
27 Male 9 32.2 27.5 −4.7 BTVC paralysis, OSA
55 Male 10 44.8 43.3 −1.5 OSA
54 Female 6 47.2 53.2 6 Subglottic stenosis
58 Female 16 38.4 37.8 −0.6 Subglottic stenosis
39 Female 12 42.6 47.1 4.5 BTVC paralysis
57 Female 9 42.9 52.4 9.5 OSA
∗ Patient was decannulated after weight loss attributable to an unrelated medical illness.
greater risk for respiratory decompensation [6]. It has also
been shown that obese individuals have a lower anerobic
threshold further suggesting an increased VO2 [5]. Several
s t u d i e sh a v ed e m o n s t r a t e dt h a tw e i g h tl o s si se ﬃcacious in
improving symptoms in patients with respiratory diseases
[1]. For patients with an anatomic airway obstruction, this
occurs in part through decreased systemic oxygen demand.
The amelioration of comorbidities such as diabetes and
hypertension is also likely to contribute positively.
Eﬀective weight loss is diﬃcult for many patients. The
social and psychological aspects of obesity are complex
and many patients are unable to achieve long-term weight
management [7]. No available studies determine if weight
loss can improve respiratory symptoms from anatomic
airway obstruction. The present study intends to determine
if properly counseled obese patients with upper airway
obstruction were compliant and successful with a prescribed
weight-loss regimen.
2. Methods
Institutional review board approval was obtained. Patients
with a body mass index (BMI) greater than 30 with anatomic
airway obstruction who were currently tracheostomy-
dependent or requiring tracheostomy pending weight loss
were selected for study. Obese patients with airway disease
received regular followup for weight measurement as well
as dietary and diabetic education referrals for weight man-
agement counseling. Dietary recommendations reﬂected the
American Diabetic Association guidelines which consisted
of 1500kcal for women and 1800kcal for men including
low-fat principles and portion control. Patients were given
an exercise regimen that included a minimum of 10 min-
utes of moderate activity daily. Patients with etiologies of
airway obstruction attributable to vocal cord paralysis and
subglottic stenosis received surgical intervention for their
airway obstruction consisting of unilateral cordotomy or
lysis of stenosis. Patients were followed at regular intervals
and weights documented. Data recorded for each patient
included age, sex, BMI at the time of tracheostomy, reason
for tracheostomy, and changes in BMI. Initial and ﬁnal study
BMI means were compared for statistical analysis using a
paired t-test. Candidates for decannulation were downsized
to a #4 Shiley (Tyco Inc., Pleasanton, Calif, USA), and
underwent capping trials for 14 days before tracheostomy
tube removal.
3. Results
A total of 15 patients, 5 male and 10 female, were recruited
for study, of which 13 had suﬃcient data available for
study. Demographic data, airway disease, and outcomes are
summarizedinTable 1.Patientagerangesfrom26to58years
old, with a mean age of 44.5 years. None of our patients
had insulin-dependant diabetes mellitus, cardiogenic ﬂuid
retention, or renal insuﬃciency. The patients were followed
overanaverageof25months,witharangeof6to48months.
The mean initial BMI for the study group was 43kg/m2 and
the ﬁnal 44.4kg/m2 for an overall gain of 1.4kg/m2.T h i sw a s
not statistically signiﬁcant at P = .32. The data for men and
women was similar at 43.6/43.3 and 42.7/44.7 initial/ﬁnal
BMI, respectively. We deﬁned signiﬁcant weight loss as a
decrease in weight of 5% over thirty days. During the study,
only two patients experienced signiﬁcant weight loss (45,
60lbs) secondary to gastrointestinal illnesses unrelated to
the weight loss measures and were subsequently successfully
decannulated. Two patients in the study are near decannula-
tion due to improving clinical status after weight loss.
4. Discussion
Obesity contributes to respiratory pathology in several ways
in the overweight patient. Anatomically, increased soft tissue
mass contributes to upper airway obstruction as in the
patient suﬀering from sleep apnea or by complicating the
course of a patient with a pre-existing airway stenosis
[2, 8]. Decreased chest wall compliance also negatively
impactsrespiration,andobeseindividualsareknowntohaveInternational Journal of Otolaryngology 3
decrease functional residual capacity and expiratory reserve
volume which improves with weight loss [2, 5].
Once thought to be a relatively inert tissue, adipose
tissue is now the subject of much study into its role as a
metabolically active tissue. It is now known that adipose tis-
sue has multiple systemic deleterious eﬀects and complicates
chronic diseases such as diabetes mellitus, hypertension,
and dyslipidemia, and it most recently has been suggested
to exacerbate respiratory diseases through the production
of inﬂammatory mediators [3, 4]. Obesity is also thought
to contribute to bronchial hyperresponsiveness through the
exacerabationofgastroespohagealreﬂux,aknownriskfactor
for asthma [3].
For many patients who are both obese and suﬀer from
airway obstruction, excess adipose tissue may be creating a
metabolic proﬁle that aggravates their respiratory disease.
Obese patients have a higher peripheral oxygen uptake than
their lean counterparts that cannot all be attributed to the
increase in work of breathing [5]. This increased oxygen
demand is likely due to the metabolic activity of adipose
cells, essentially stealing oxygen from skeletal muscles during
exercise and resulting in a low anerobic threshold.
Extraadiposetissuecanalsocausediﬃcultiesforpatients
in that the extratissue creates increased work that the mus-
culoskeletal system must then overcome. The added demand
on muscles that are already relatively oxygen-deprived likely
contributes to the dyspnea felt by obese patients during
exertion. Maniscalco et al. quantiﬁed increased performance
and decreased dyspnea in overweight patients who lost
weight following bariatric surgery [2]. The combined eﬀect
of these elements, the mechanical disruption of respiration,
production of inﬂammatory mediators, burden on the
musculoskeletal system, and increase in oxygen demand
likely have a synergistic eﬀect on the obese with an airway
obstruction. For many of the patients studied, airway
dysfunction is likely not due to visceral fat accumulation
as several patients continued to progress to a point where
tracheostomy was required. Obesity remains a detriment
to respiratory function: decreased chest wall compliance,
increased work load, increased oxygen demand, and possible
metabolic eﬀects.
The management of anatomic airway obstruction and
obesity is complex. The surgical treatment of bilateral vocal
cord paralysis, for example, is an ongoing compromise of
respiration,voice,anddeglutition.Oncetheoptimumglottic
airway with respect to these functions has been achieved,
other than permanent tracheostomy, signiﬁcant weight loss
is the only remaining option for many patients. Despite the
availability of deﬁnitive airway interventions, it is likely that
many obese patients would exhibit symptomatic dyspnea
even with an anatomically normal airway. Unfortunately
for many patients with upper airway obstruction, long-
term weight loss is not achieved despite the promise of
improvedrespiratoryfunctionwhichhasasigniﬁcantimpact
on quality of life and other comorbid diseases.
The current study is not intended as a clinical trial of dif-
ferent treatments for airway disorders but simply to provide
“real-world”outcomeinformation onconservativemeasures
for weight loss in a small, airway-diseased population. A
common situation that occurs is weighing between diﬃcult
surgical options that carry signiﬁcant risk of failure; risk that
could be oﬀset by signiﬁcant weight reduction. However,
despite the obvious motivating factor of ending dependence
on an indwelling tracheostomy, signiﬁcant weight loss was
not achieved by the group as a whole using conservative
measures without pharmacotherapy. In the majority of
cases, this was due to noncompliance with the dietary
and exercise recommendations. In a large population-based
study, signiﬁcant long-term weight loss was achieved in
only 28% of patients receiving intense multidisciplinary
intervention for their obesity [7]. Despite the many ways
that obesity complicates airway disorders, improvement
of respiratory and ventilatory function and the resulting
presumed positive impact on quality of life from weight loss
did not provide signiﬁcant motivation for weight loss in
our patient population. Clearly, if signiﬁcant weight loss is
to be achieved, more aggressive measures, such as bariatric
surgery, must be seriously considered.
Patientswithetiologiesofairwayobstructionattributable
tovocalcordparalysisandsubglotticstenosisreceivedappro-
priate surgical intervention for their airway obstruction,
but still did not achieve decannulation. This failure was
attributed to continued obesity.
5. Conclusion
The challenges for clinicians and patients who struggle with
obesity are many: the disease touches nearly every aspect of
the patient’s life and is certainly one of the most diﬃcult
conditions to treat. Social and economic limitations likely
conspire to complicate weight loss, and even when patients
have all available resources and support at hand, long-term
results are still diﬃcult to achieve. At the end, it may prove
diﬃcult for medicine to address a disease whose etiology
is more cultural than physiological. Therefore, sustained
interventions at multiple levels are likely required if weight
loss is to be an important part of airway management.
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